GlassScriptPhysician profile
Manaf Assafin
NPI 1407260896
$27,405.03
in general payments reported to CMS, 2019-2025
14 companies · $9,502 in 2025
The $9,502 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,468 · 2023: $5,821 · 2024: $11K · 2025: $9,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Travel and Lodging: $6,883 · Consulting Fee: $1,000 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,772.80 |
| Travel and Lodging | $6,883.01 |
| Consulting Fee | $1,000.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,879.25 | 2023-2025 | Corevalve Evolut R, Onyx Frontier, Ffrangio |
| Edwards Lifesciences Corporation | $5,812.00 | 2022-2025 | Pascal, Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $4,742.92 | 2023-2025 | Navitor, Triclip, Mitraclip |
| Inari Medical, INC. | $3,160.19 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $2,624.49 | 2023-2025 | Avvigo Guidance System, Watchman Flx, Comet |
| Abiomed | $1,153.11 | 2024-2025 | Impella |
| Stryker Corporation | $948.60 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Shockwave Medical, INC | $787.06 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $126.72 | 2025 | Alphavac |
| Novartis Pharmaceuticals Corporation | $60.26 | 2024-2025 | |
| Teleflex LLC | $49.92 | 2024 | Manta |
| Philips North America LLC | $35.60 | 2025 | Mcot |
| United Therapeutics Corporation | $24.91 | 2025 | Tyvaso |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manaf Assafin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.